Cellectar biosciences to present at the targeted radiopharmaceuticals summit europe

Florham park, n.j., dec. 05, 2023 (globe newswire) -- cellectar biosciences, inc. (nasdaq: clrb), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that jarrod longcor, cellectar's chief operating officer (coo), will deliver a presentation and co-chair the 5th annual targeted radiopharmaceuticals summit europe, being held december 5-7, 2023 in berlin, germany.
CLRB Ratings Summary
CLRB Quant Ranking